These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 30945355)

  • 1. Societal value of newborn screening for severe combined immune deficiency in Arkansas: An economic analysis.
    Hays LH
    Public Health Nurs; 2019 Jul; 36(4):541-544. PubMed ID: 30945355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic neonatal screening for severe combined immunodeficiency and severe T-cell lymphopenia: Analysis of cost-effectiveness based on French real field data.
    Clément MC; Mahlaoui N; Mignot C; Le Bihan C; Rabetrano H; Hoang L; Neven B; Moshous D; Cavazzana M; Blanche S; Fischer A; Audrain M; Durand-Zaleski I
    J Allergy Clin Immunol; 2015 Jun; 135(6):1589-93. PubMed ID: 25840725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fiscal implications of newborn screening in the diagnosis of severe combined immunodeficiency.
    Kubiak C; Jyonouchi S; Kuo C; Garcia-Lloret M; Dorsey MJ; Sleasman J; Zbrozek AS; Perez EE
    J Allergy Clin Immunol Pract; 2014; 2(6):697-702. PubMed ID: 25439359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The case for severe combined immunodeficiency (SCID) and T cell lymphopenia newborn screening: saving lives…one at a time.
    Quinn J; Orange JS; Modell V; Modell F
    Immunol Res; 2020 Feb; 68(1):48-53. PubMed ID: 32128663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-Effectiveness/Cost-Benefit Analysis of Newborn Screening for Severe Combined Immune Deficiency in Washington State.
    Ding Y; Thompson JD; Kobrynski L; Ojodu J; Zarbalian G; Grosse SD
    J Pediatr; 2016 May; 172():127-35. PubMed ID: 26876279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Markov model to analyze cost-effectiveness of screening for severe combined immunodeficiency (SCID).
    Chan K; Davis J; Pai SY; Bonilla FA; Puck JM; Apkon M
    Mol Genet Metab; 2011 Nov; 104(3):383-9. PubMed ID: 21810544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overview of 15-year severe combined immunodeficiency in the Netherlands: towards newborn blood spot screening.
    de Pagter AP; Bredius RG; Kuijpers TW; Tramper J; van der Burg M; van Montfrans J; Driessen GJ;
    Eur J Pediatr; 2015 Sep; 174(9):1183-8. PubMed ID: 25875249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of newborn screening for severe combined immunodeficiency.
    Van der Ploeg CPB; Blom M; Bredius RGM; van der Burg M; Schielen PCJI; Verkerk PH; Van den Akker-van Marle ME
    Eur J Pediatr; 2019 May; 178(5):721-729. PubMed ID: 30805731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and economic aspects of newborn screening for severe combined immunodeficiency: DEPISTREC study results.
    Thomas C; Durand-Zaleski I; Frenkiel J; Mirallié S; Léger A; Cheillan D; Picard C; Mahlaoui N; Riche VP; Roussey M; Sébille V; Rabetrano H; Dert C; Fischer A; Audrain M
    Clin Immunol; 2019 May; 202():33-39. PubMed ID: 30946917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Newborn screening for severe combined immune deficiency (technical and political aspects).
    Kobrynski L
    Curr Opin Allergy Clin Immunol; 2015 Dec; 15(6):539-46. PubMed ID: 26485096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Newborn screening for SCID: lessons learned.
    Buelow BJ; Verbsky JW; Routes JM
    Expert Rev Hematol; 2016 Jun; 9(6):579-84. PubMed ID: 27139719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Newborn Screening for SCID and Other Severe Primary Immunodeficiency in the Polish-German Transborder Area: Experience From the First 14 Months of Collaboration.
    Giżewska M; Durda K; Winter T; Ostrowska I; Ołtarzewski M; Klein J; Blankenstein O; Romanowska H; Krzywińska-Zdeb E; Patalan MF; Bartkowiak E; Szczerba N; Seiberling S; Birkenfeld B; Nauck M; von Bernuth H; Meisel C; Bernatowska EA; Walczak M; Pac M
    Front Immunol; 2020; 11():1948. PubMed ID: 33178177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for and treatments of congenital immunodeficiency diseases.
    Verbsky J; Routes J
    Clin Perinatol; 2014 Dec; 41(4):1001-15. PubMed ID: 25459787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe Combined Immunodeficiency: A Review for Neonatal Clinicians.
    Michniacki TF; Seth D; Secord E
    Neoreviews; 2019 Jun; 20(6):e326-e335. PubMed ID: 31261096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The case for mandatory newborn screening for severe combined immunodeficiency (SCID).
    Gaspar HB; Hammarström L; Mahlaoui N; Borte M; Borte S
    J Clin Immunol; 2014 May; 34(4):393-7. PubMed ID: 24691999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonsevere combined immunodeficiency T-cell lymphopenia identified through newborn screening.
    Patrawala M; Kobrynski L
    Curr Opin Allergy Clin Immunol; 2019 Dec; 19(6):586-593. PubMed ID: 31490207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States.
    Kwan A; Abraham RS; Currier R; Brower A; Andruszewski K; Abbott JK; Baker M; Ballow M; Bartoshesky LE; Bonilla FA; Brokopp C; Brooks E; Caggana M; Celestin J; Church JA; Comeau AM; Connelly JA; Cowan MJ; Cunningham-Rundles C; Dasu T; Dave N; De La Morena MT; Duffner U; Fong CT; Forbes L; Freedenberg D; Gelfand EW; Hale JE; Hanson IC; Hay BN; Hu D; Infante A; Johnson D; Kapoor N; Kay DM; Kohn DB; Lee R; Lehman H; Lin Z; Lorey F; Abdel-Mageed A; Manning A; McGhee S; Moore TB; Naides SJ; Notarangelo LD; Orange JS; Pai SY; Porteus M; Rodriguez R; Romberg N; Routes J; Ruehle M; Rubenstein A; Saavedra-Matiz CA; Scott G; Scott PM; Secord E; Seroogy C; Shearer WT; Siegel S; Silvers SK; Stiehm ER; Sugerman RW; Sullivan JL; Tanksley S; Tierce ML; Verbsky J; Vogel B; Walker R; Walkovich K; Walter JE; Wasserman RL; Watson MS; Weinberg GA; Weiner LB; Wood H; Yates AB; Puck JM; Bonagura VR
    JAMA; 2014 Aug; 312(7):729-38. PubMed ID: 25138334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of infants identified as having severe combined immunodeficiency by means of newborn screening.
    Dorsey MJ; Dvorak CC; Cowan MJ; Puck JM
    J Allergy Clin Immunol; 2017 Mar; 139(3):733-742. PubMed ID: 28270365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Use of Economic Evaluation to Inform Newborn Screening Policy Decisions: The Washington State Experience.
    Grosse SD; Thompson JD; Ding Y; Glass M
    Milbank Q; 2016 Jun; 94(2):366-91. PubMed ID: 27265561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional Confirmation of DNA Repair Defect in Ataxia Telangiectasia (AT) Infants Identified by Newborn Screening for Severe Combined Immunodeficiency (NBS SCID).
    Barmettler S; Coffey K; Smith MJ; Chong HJ; Pozos TC; Seroogy CM; Walter J; Abraham RS
    J Allergy Clin Immunol Pract; 2021 Feb; 9(2):723-732.e3. PubMed ID: 32818697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.